What are the typical echocardiographic findings and their incidence in patients with rheumatoid arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Echocardiographic Findings in Rheumatoid Arthritis

Critical Clarification

The evidence provided pertains almost entirely to rheumatic heart disease (RHD) from acute rheumatic fever, NOT rheumatoid arthritis (RA). These are completely different conditions with distinct cardiac manifestations. I will answer based on the limited research evidence available for rheumatoid arthritis specifically.

Direct Answer

Cardiac abnormalities on echocardiography are extremely common in rheumatoid arthritis patients, occurring in 52-80% of cases, with the majority being asymptomatic. The most frequent findings are mitral regurgitation (80%), left ventricular diastolic dysfunction (36-66%), and pulmonary hypertension (21-31%) 1, 2, 3.

Specific Echocardiographic Findings and Their Incidence

Valvular Abnormalities

  • Mitral regurgitation: 80% of RA patients (versus 37% in controls, p<0.001) 2
  • Valvular involvement overall: 45.8% 1
  • Aortic regurgitation: 17-33% (not significantly different from controls) 2, 3
  • Tricuspid regurgitation: 17-23% 2, 3
  • Mitral valve prolapse: 6% 4

Ventricular Dysfunction

  • Left ventricular diastolic dysfunction: 36-66% of RA patients (versus 13-43% in controls) 1, 3
    • More common in older patients
    • Associated with extra-articular manifestations
  • Subclinical left ventricular myocardial damage (by Global Longitudinal Strain): 37.5% (versus 16.6% in controls, p<0.01) 1
    • Mean GLS: -17.8 ± 2.9 in RA versus -19.4 ± 1.9 in controls
  • Reduced ejection fraction (<64%): 9% 5
  • Left ventricular hypertrophy: 22.2% (versus 6.9% in controls, p<0.01) 1

Pulmonary Hypertension

  • Elevated pulmonary artery systolic pressure (≥30 mmHg): 31% 5
  • Pulmonary artery systolic pressure >35 mmHg: 21% (versus 4% in controls, p=0.03) 3
  • Primary pulmonary hypertension (without significant cardiac or lung disease): 21% 5

Other Findings

  • Pericardial effusion: 2.8-13% 1, 2
  • Aortic atheroma: 40% (missed by transthoracic echo in 83% of cases) 2
  • Echo-generating nodules (rheumatoid nodules): Rare, seen on valves in 3-10% 2

Key Clinical Correlations

Echocardiographic abnormalities correlate significantly with:

  • Disease activity (p<0.01) 1
  • Number of painful joints (p<0.01) 1
  • Functional impairment (HAQ score, p=0.01) 1
  • CRP levels (p<0.01) 1
  • Corticosteroid use and dose (p=0.02 and p=0.01) 1
  • Higher Steinbrocker stage 4
  • Longer disease duration 4

Critical Clinical Implications

80.6% of cardiac abnormalities in RA are asymptomatic 1, making systematic screening essential rather than symptom-driven evaluation. The high prevalence of subclinical myocardial dysfunction detected by strain imaging (37.5%) suggests that conventional ejection fraction measurements significantly underestimate cardiac involvement 1.

Transesophageal echocardiography is superior to transthoracic echo for detecting aortic atheroma (missed in 83% by transthoracic approach) and may reveal additional valvular pathology 2.

Practical Screening Approach

Given the 52-80% prevalence of cardiac abnormalities and their predominantly asymptomatic nature, systematic echocardiographic screening should be considered in all RA patients, particularly those with:

  • High disease activity
  • Extra-articular manifestations
  • Long disease duration
  • Corticosteroid therapy
  • Advanced Steinbrocker stage

Include strain imaging (GLS) when available to detect subclinical left ventricular dysfunction not apparent by ejection fraction alone 1.

Related Questions

Can hydroxyurea be used to treat rheumatoid arthritis?
What non‑pharmacologic strategies can be used to delay progression of early rheumatoid arthritis without medication?
Can spinal anesthesia be safely performed in a patient with rheumatoid arthritis, and what pre‑operative assessments and precautions (including cervical spine stability, medication management, infection status, and coagulation profile) are required?
What are the anesthesia considerations for a patient with rheumatoid arthritis?
Which laboratory tests should be ordered for a patient with suspected rheumatoid arthritis?
In a 19-year-old sexually active female presenting with mild lower abdominal pain and copious vaginal discharge, which sexually transmitted infections should be screened for and why, what physical examinations are indicated, what are the top three differential diagnoses, which STIs are reportable to the state health department and what information must be included in the report, and is expedited partner therapy legal and within my scope of practice in my state?
For a person with superficial bruising, should ice (cold compress) or heat (warm compress) be applied?
What is the appropriate evaluation and management of hallucinations occurring after a stroke?
Is it safe to take ciprofloxacin while on Gemtesa (vibegron)?
When using fluticasone nasal spray and azelastine nasal spray together, how long should I wait between the sprays?
In a generally healthy adult, what amount of liposomal vitamin C can be effectively absorbed, and should high‑dose vitamin C be administered in divided doses throughout the day?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.